14 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
American Music Therapy Association Arthur Flagler Fultz Research Award
The Arthur Flagler Fultz Award is now $15,000
Save paper and mailing costs: Applications will be accepted via electronic submission!
All applications must be emailed to the AMTA National Office and received by 5:00 pm EST on May 2, 2014 to be considered eligible.
Submit your application to firstname.lastname@example.org using the electronic application form for the 2014 Fultz Award.
Call for Nominations: 11th Annual Edward M. Scolnick Prize in Neuroscience
The McGovern Institute is now accepting nominations for the 11th annual Edward M. Scolnick Prize in Neuroscience.
The Edward M. Scolnick Prize Neuroscience is awarded annually by the McGovern Institute to recognize outstanding advances in the field of neuroscience. The prize, which is endowed through a gift from Merck to the McGovern Institute, consists of a $100,000 award, plus an inscribed gift. The recipient of the Scolnick Prize presents a public lecture at the McGovern Insitute for Brain Research in the spring of 2014. A gala dinner for the recipient and invited guests follows the prize lecture.
Nomination Deadline: December 15, 2013
Candidates for the award must be nominated by individuals affiliated with universities, hospitals, medicals schools, or research institutes, with a background in neuroscience. Self-nomination is not permitted. Each nomination should include:
• A biosketch or CV of the nominee
• A letter of nomination with a summary and analysis of the major contributions of the nominee to the field of neuroscience
• Up to two representative reprints will be accepted
• Members of the selection committee and faculty affiliated with MIT are not eligible
• Announcement of the award recipient will be made in February 2013
• Recipient must attend all events to be awarded the prize
Send nomination packet to:
Attn: Scolnick Prize Nomination
McGovern Institute for Brain Research
Massachusetts Institute of Technology
77 Massachusetts Avenue 46-3160
Cambridge, MA 02139
For more information: McGovern@mit.edu
Rockefeller University Summer Undergraduate Research Fellowship Program
The Rockefeller University Summer Undergraduate Research Fellowship (SURF) program provides a unique opportunity for undergraduates to conduct laboratory research. SURF students work with leading scientists in a broad range of areas including biochemistry; structural biology and chemistry; molecular, cell and developmental biology; immunology; virology and microbiology; neuroscience; physics; and mathematical biology.
The program is designed to provide qualified, highly motivated college students majoring in the life or physical sciences, an opportunity to experience laboratory research. Each year, outstanding college sophomores and juniors are chosen from a large pool of applicants. SURF students are matched according to their stated field of interest with faculty, postdoctoral researchers or graduate students. These mentors volunteer to help design and supervise individualized summer projects for their students. The 18 students accepted into the SURF program will receive a stipend of $4,000.00 for the 10-week period of June 2 through August 8, 2014. Free housing will be provided for students who cannot commute.
Applicants to the SURF Program must submit:
The completed on-line application form.
A two-page summary statement describing the applicant's academic background, scientific interests, research experience (if any) and career goals. Applicants should discuss how they would benefit from the SURF Program.
An official transcript (sealed by the university registrar).
Two letters of recommendation preferably from professors or mentors who can evaluate the applicant based on performance in current or completed research projects. (These letters are critical for our selection process). Letters of recommendation should be submitted online. If letters of recommendation are not submitted online, they must be mailed in separate sealed envelopes, signed across the seal, to the address below.
Any documents not submitted online should be mailed to:
Office of Graduate Studies
The Rockefeller University
1230 York Avenue, Box 177
New York, NY 10065-6399
Applications must be submitted no later than February 1, 2014. Completed applications will be reviewed in the order they are received. Final decisions will be made by mid-March 2014. It is imperative that applicants provide contact information for the first two weeks of March.
SURF applicants should state a preference for working in particular laboratories or areas of research; however, we cannot guarantee that specific preferences will be met. For a listing of faculty members and a brief description of their research, we encourage you to obtain further in-depth information by viewing the Rockefeller Web site at http://www.rockefeller.edu/research/. Please be advised that placement in laboratories is centralized through the Dean's Office. Students are neither expected nor encouraged to secure their own lab arrangements.
Emergency Medicine Foundation/Emergency Nurses Association Foundation Directed Team Grant Research Award
Deadline for receipt of application: January 10, 2014
The Emergency Medicine Foundation and the ENA Foundation jointly award this grant to facilitate collaboration between the disciplines and to improve clinical research in emergency care. This grant is intended for physician and nurse researchers to combine their expertise to develop, plan, and implement clinical research in emergency care.
The EMF/ENA Foundation Directed Team Grant Research Award program awards one $50,000 grant for research over a one year period.
PURPOSE OF THE EMF/ENA FOUNDATION DIRECTED TEAM GRANT RESEARCH AWARD
This grant exists because of the donation of funds by both the Emergency Medicine Foundation and the ENA Foundation. It was funded specifically to support work that arises from a true physician-nurse partnership in a clinical research area pertinent to the practice of emergency medicine. As such, the applicants must provide evidence of a true collaborative effort between physician and nurse professionals and must delineate the relative roles of the participants in terms of protocol development, data collection, and manuscript preparation.
This request for proposals specifically seeks research related to the topic of ED overcrowding and ED workplace violence. Proposals may focus on a number of related areas, including: definitions and outcome measures of ED overcrowding, causes and effects of ED overcrowding, potential solutions to the problem of ED overcrowding, the scope and problem of ED workplace violence, definitions and metrics for measuring ED workplace violence, and projects that address coping with workplace violence.
Applications will be accepted from any emergency medicine physician/nurse team working full or part time in emergency care at any domestic, Joint Commission-accredited institution. The nurse principal investigator must:
• Be a current Emergency Nurses Association (ENA) member
• Not have served on the ENA board of directors, ENA Foundation board of trustees, or ENA Foundation grant review team in the immediate past three years
The applicants must demonstrate that access to suitable caseload, patient population or database will be available for study during the funding period. The applicants must submit letters of support from their director/chair stating that adequate funds and release time will be available. Research involving human subjects must be approved by the institutional review board (IRB), or its equivalent, and a copy of the approval or pending approval sent with this application. IRB approval must be documented prior to dispensation of EMF funds.
EVALUATION OF APPLICATIONS
Emergency medicine specialists who are actively involved in clinical or health services emergency medicine research will review each application. The review committee will be comprised of members of the Scientific Review Committee of the American College of Emergency Physicians (this committee performs peer review for EMF) and members of the ENA Foundation. Each application will be judged according to 1) significance to the topic of ED overcrowding or ED workplace violence, 2) demonstration of a collaborative effort between physician and nurse researchers along with the applicants’ background, commitment, and potential as a researchers in emergency medicine, 3) the scientific merit, methodology and originality of the research project, 4) appropriateness of budget, and 5) the documented willingness of the sponsoring institution to provide the necessary facilities and support to complete the projects as described. Additional elements that contribute to the score will be project feasibility and the clear statement of measurable aims. Feasibility may be enhanced by inclusion of appropriate hospital administrative leaders. Purely descriptive projects or surveys are unlikely to be successful. Preliminary data from the research institution is highly encouraged. In constructing the project goals, applicants are encouraged to be aware of the June 14, 2006 report by the Institute of Medicine Hospital-Based Emergency Care: At the Breaking Point, and its findings relative to the impact of overcrowding in the emergency department. The final funding decision will be made jointly by the Emergency Medicine Foundation Board of Trustees and the ENA Foundation. All decisions are final.
Limitations on Awards
Funds may be used for materials, supplies, services (e.g., respiratory therapy, statistical consultation), or to provide salary support for ancillary staff (e.g., technicians, data collectors). Capital equipment expenditures (cost greater than $500 and with a life of over one year) must be justified in the budget. Payments will be made to the principal investigators’ institution that will be responsible for administering the funds. Neither the Emergency Medicine Foundation nor the ENA Foundation will be responsible for institutional overhead, cost for publications, travel, renovations, or secretarial support. Detailed audited financial reports may be required. EMF and ENA Foundation are not fiscally responsible for funds necessary for the project's completion.
New Investigator Awards in Alzheimer's Disease
Funded by The Rosalinde and Arthur Gilbert Foundation and The Diane and Guilford Glazer Foundation, the major goal of this partnership program is to support important research in areas in which more scientific investigation is needed to improve the prevention, diagnosis, and treatment of Alzheimer's disease. The program also serves to encourage junior investigators in the United States and Israel to pursue research and academic careers in the neurosciences, and Alzheimer's disease in particular.
Projects in basic and translational research related to Alzheimer's disease (AD) that are clinically relevant, will be considered. Projects that focus on healthy brain aging are also considered. For one of the awards, priority may be given to an investigator with a research interest related to healthy brain aging. Areas of research could for example include learning and memory, nutrition, exercise, cardiovascular risk factors, as they relate to the brain and the aging process.
Examples of promising areas of research include, but are not limited to:
Basic mechanisms of aging in the central nervous system
Learning and memory
The Biology and Pathobiology of Synapses
Genetics of AD
Neuroimaging and precursors of AD
Cellular and Molecular pathways of AD
Biological Markers of AD
Exercise, nutrition and dietary factors
Neurogenesis and AD
Impact of environmental agents in CNS aging and early AD
Cardiovascular and cerebrovascular factors
It is anticipated that up to 4 grants of $100,000 each will be awarded in 2014. Applicants may propose to use the award over the course of one or two years as justified by the proposed research. Up to 8% of funds may be budgeted for overhead or indirect costs (not to exceed $7,407). Funding will begin July 1, 2014.
The applicant must be an independent investigator with independent research space as described in a form completed by the Dean or Department Chair, and must be no more than 10 years beyond start of postdoctoral research training as of July 1, 2014. Exceptions to the ten year rule may be requested for unusual circumstances by emailing an NIH-style biosketch to AFAR at email@example.com. The proposed research must be conducted at any type of not-for-profit setting in the United States or Israel.
The New Investigator Awards in Alzheimer's Disease do not provide support for:
Postdoctoral fellows in the laboratory of a senior investigator
Investigators who have already received major extramural funding (such as an R01 or NSF equivalent grant)
Senior faculty, i.e. at the rank of Associate Professor level or higher
NIH Intramural program employees
Applicants who are conducting research at a for-profit institution, or at an institution outside of the United States or Israel
Applicants cannot apply for the 2014 AFAR Research Grant Program or Glenn/AFAR BIG Program. Applications for this program will be considered for the AFAR Research Grant if deemed competitive.
Five criteria are used to determine the merit of an application:
Qualifications of the applicant;
Quality of the proposed research;
Relevance of the proposal to how mechanisms of aging may lead to AD or encourage healthy brain aging;
Excellence of the research environment;
Likelihood that the project will advance the applicant's career in basic research on the mechanisms of aging and AD or healthy brain aging
For one of the awards, priority may be given to an investigator with a research interest related to healthy brain aging provided the application is deemed to meet the highest standards set by AFAR's Research Committee.
The deadline for receipt of all Letters of Intent is December 16, 2013 at 5:00 p.m. EST. Please refer to the New Investigator LOI instructions. Incomplete LOIs cannot be considered. All applications and supporting materials must be submitted through the website www.afar.org/grants/. The Letters of Intent will be reviewed by a committee. Applicants will be notified by January 31, 2014, and a subset of applicants will be invited to submit a full application by March 17, 2014.
All LOI candidates who are invited to submit applications must have it endorsed by their institution. Final awards are announced by early June. The award start date is July 1, 2014. AFAR will not provide reviewer critiques to any applicants at any review level.
Investigators will be required to submit a brief narrative report on the progress of their research five months after the start date of the award. Final narrative and financial reports are required within three months following the end date of the award.
The award recipients are expected to attend the AFAR Grantee Conference which convenes AFAR grant recipients, mentors and leaders in the field to review and disseminate the research progress of the grantees and their findings. The meeting encourages networking, facilitates collaborations, and enhances the development of leadership. In addition, grant recipients of the New Investigator Awards in Alzheimer's are expected to attend a special session at the grantee conference.
Progressive MS Alliance Challenge Awards and Infrastructure Awards
Deadline - January 31, 2014
The Progressive MS Alliance (previously known as the International Progressive MS Collaborative) is working together to find answers and develop solutions to end progressive MS. The Alliance aims to build upon current research efforts and connect resources and experts around the world. The Alliance is pleased to announce two new funding initiatives designed to accelerate research focused on progressive MS.
1) Challenge Awards -These are designed to encourage and nurture scientific innovation in the following focus areas:
-- Phenotype/Genotype and pathophysiological mechanisms of progressive MS
-- Development of new and existing pre-clinical models for progressive disease based on community consensus building
-- Discovery and validation of proof of concept biomarkers
-- Innovative designs for proof of concept trials of therapeutic agents or therapeutic strategies
2) Infrastructure Awards -These are designed to promote and enhance data sharing and knowledge management and encourage collaboration among researchers by developing enabling technologies and infrastructure for data sharing to support one or more of the Alliance priority research areas.
Support for each of these awards is limited to a maximum of €75,000 in total costs for 12 months. This request for applications (RFA) is open to all international researchers in academic and other non-profit organizations, as well as to researchers in commercial organizations.
The application deadline is January 31, 2014. Details on how to apply for funding can be found at http://www.endprogressivems.org.
To learn more about the Progressive MS Alliance please visit our web site, www.endprogressivems.org.
We are looking forward to innovative proposals from around the world and from all disciplines. If you have an innovative idea or concept, please apply.
McKnight Endowment Fund for Neuroscience Scholar Award
Applications for the McKnight Endowment Fund for Neuroscience Scholar Award due January 6, 2014.
The McKnight Endowment Fund for Neuroscience supports innovative research designed to bring science closer to the day when diseases of the brain can be accurately diagnosed, prevented, and treated. To this end, the McKnight Endowment Fund for Neuroscience invites applications for the 2014 McKnight Scholar Awards.
These awards were established to encourage emerging neuroscientists to focus on disorders of learning and memory. Applicants for the McKnight Scholar Awards must demonstrate interest in solving important problems in relevant areas of neuroscience, including the translation of basic research to clinical neuroscience. Awards are given to exceptional young scientists who hold the M.D. and/or Ph.D. degree and who are in the early stages of establishing an independent laboratory and research career. Traditionally, successful candidates have held faculty positions for at least one year. Up to six McKnight Scholars each will receive three years of support, beginning July 1, 2014.
Eligibility. Applicants must have the following:
• an M.D. and/or Ph.D. degree and have completed formal postdoctoral training;
• tenure-track status at a U.S.-based sponsoring institution, to which awards will be paid;
• a record of meritorious research in areas pertinent to the interests of the Endowment Fund;
• no more than four years of experience in an independent/tenure-track faculty position (exceptions may be made to account for parental leave);
• evidence of a commitment to a career in neuroscience; and
•U.S. citizenship or lawful permanent resident status.
Please note: applicants must be in a tenure-track position; research faculty with annually renewable contracts are not eligible.
Applicants may not:
• be employees of the Howard Hughes Medical Institute or scientists within the intramural program of the National Institutes of Health;
• apply in more than two rounds of competition;
• apply for continued postdoctoral support;
• be tenured already; or
• hold another McKnight award.
Amount and Purpose of Support. Each McKnight Scholar will receive $75,000 annually in 2014, 2015, and 2016. Funds may be used in any way that will facilitate development of the Scholar’s research program, but not for indirect costs.
Selection Process. A review committee will evaluate applications and invite a select few to interview with the committee. Applicants selected will be notified by March 28, 2014. The interviews are scheduled for Friday, April 25, 2014 in New York City. The committee will then recommend candidates to the Board of Directors of the Endowment Fund for final decision. Awards will be announced on or before May 17, 2014.
Filing of Scholar Award Application. Applications must arrive no later than January 6, 2014. Please email one PDF of the completed application to firstname.lastname@example.org (references will be submitted separately). If you do not receive confirmation of receipt within a week of submission, please call Eileen at 612-333-4220.
Michael J. Fox Foundation for Parkinson's Research Target Validation Program
Fall 2014 Review Cycle
Informational Conference Call*: March 26, 2014 at 12pm US ET
Pre-proposals Due: May 28, 2014 – 6pm US ET
Full Proposal Invitations: June 18, 2014
Full Proposals Due (by invite only): August 6, 2014 – 6pm US ET
Anticipated Award Announcement: October 2014
Anticipated Funding: November 2014
*MJFF will hold a 45-minute conference call on the dates and times listed above to clarify and explain the goals of this funding initiative and answer applicant questions. To participate in the call and receive call-in details, please RSVP via email to email@example.com.
The Target Validation program supports work to determine whether manipulation of a defined biological target provides a disease-relevant beneficial outcome in a whole animal, mammalian model of PD. MJFF does not have any pre-conceived preferences for particular targets submitted to the Target Validation program. However, we recommend applicants consider the following:
The target should be clearly defined, such as:
A specific gene
A structural/functional feature of a protein (e.g., its enzymatic activity, protein conformation or ability to interact with other proteins)
Proposals seeking to manipulate global pathways without a clear target are not encouraged
Applicants may propose a variety of methods to manipulate a target, including but not limited to:
Use of pharmacological tools
Supporting data/explanation of the proposed pharmacological tool must be addressed in the body of the proposal.
Parameters that should be discussed include:
Selectivity for the target of interest
Pharmacokinetic/Pharmacodynamic measures that have been/will be assessed
Measures of target engagement
Use of biologic strategies such as:
Viral vector-mediated gene delivery, etc.
In Vivo Models
Applicants may also propose use of models appropriate for the target proposed including:
Previously established genetically engineered animal models including:
Knockout models where the target/gene of interest is deleted
Transgenic models whereby the target/gene of interest is over-expressed
Investigators should proposed to examine PD-relevant features or sensitivity to PD-associated factors during the course of their studies
Proposals may include intermediate tests using in vitro, ex vivo and/or model organisms (e.g., Drosophila, C. elegans) to optimize the ideal target manipulation strategy
These proposals must ultimately include within the grant funding period an evaluation of the target manipulation in a whole-animal mammalian model of PD
Note: The following types of proposals are not appropriate for the Target Validation program:
Proposals focused on new target identification and proposals testing cellular transplantation approaches.
Proposals seeking to generate new genetic (knockin, knockout, transgenic) models
Investigators seeking guidance to develop new models around their target are encouraged to contact firstname.lastname@example.org
Applicants seeking support for therapeutic development should submit to the Therapeutic Pipeline Program or contact MJFF research staff for guidance.
MJFF will commit up to $10 million to the Edmond J. Safra Core Programs for PD Research with the intention to support multiple awards. The Target Validation program supports two-year grants up to $250,000 total costs inclusive of both direct and indirect costs. The total annual direct costs cannot exceed $100,000. No more than 25% (Academic institutions) or 10% (for-profit organizations) of the direct costs may go to indirect costs.
Applications may be submitted by:
U.S. and non-U.S. biotechnology/pharmaceutical companies or other for-profit entities, either publicly or privately held,
U.S. and non-U.S. entities, public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments, and eligible agencies of the federal government.
Post-doctoral fellows are NOT eligible to apply as Principal Investigators to the Target Validation program.
Request for Applications: Templeton Science of Prospection Research Awards
Supported by a grant from the John Templeton Foundation, the University of Pennsylvania Positive Psychology Center has established the Templeton Science of Prospection Awards to advance research the scientific understanding of prospection, or the mental representation of possible futures.
Up to fifteen (15), 22- to 24-month grants averaging $150,000 will be awarded to researchers worldwide who hold the Ph.D or equivalent, are at the rank of Assistant, Associate, or Full Professor, and have maintained their own independent laboratory for no more than 12 years.
Research topics of interest include, but are not limited to, explorations of the following domains of prospection:
To Apply: Interested applicants should submit a Letter of Intent and a Curriculum Vita by January 1, 2014.
The official Request for Proposals and application details for this opportunity can be found on the Prospective Psychology website: http://sites.sas.upenn.edu/prospection
American Academy of Neurology Medical Student Summer Research Scholarship
1) The project is to be undertaken in either an institutional, clinical, or laboratory setting that has ongoing programs of research, service, or training, or in a private practice setting.
2) The research being conducted MUST be neuroscience based i.e. basic neuroscience. Note: Research done in overlapping fields of cognition/psychology, PMR for neurologic dysfunction or overlap with ENT are acceptable.
3) There must be a registered SIGN chapter at the student applicant’s institution; there does not need to be a SIGN chapter at the institution where the research will be done, but this is encouraged.
4) Applicants must be current AAN members and SIGN chapter members at their institution at the time of application submission.
5) Applicants must not have received the scholarship previously.
6) Sponsoring investigators must confirm that local IRB requirements regarding the student’s role in human subjects research have been or are being addressed.
7) If your project preceptor and SIGN faculty advisor are the same person, please provide two separate letters.
8) The student should write the proposal, clearly delineating his/her role in the project. Applications in which the role of the student is not clearly defined will not be considered.
9) Any publications resulting from the funded project must acknowledge the support of the American Academy of Neurology (AAN). Upon publication, copies should be forwarded to the AAN.
10) Multiple sources of funding is allowed; however, applicants must provide information regarding what funds have been applied for and/or received.
11) Preference will be given to first-time researchers. Projects already completed will not be considered.
12) Scholarship winners are encouraged to submit their abstract to the AAN for the Annual Meeting Scientific Program (online at www.call4abstracts.com/aan/)
13) Scholarship winners will be encouraged to display their research results at the poster session during the SIGN meeting and CD/PD Conference during the Educational Tools Session at the AAN Annual Meeting.
Student will submit by or before February 8, 2014:
1) 1-2 page project proposal
2) 1-2 page Curriculum Vitae
3) 2 letters of recommendation: one from the project preceptor and one from the SIGN faculty advisor or from neurology or neuroscience faculty
Student will include in the Project Proposal:
1) Student name and title of project
2) Students clearly defined role in the project
3) Time frame of project
4) Clearly defined goals
5) Statement of how the goals will be completed in the time frame specified
6) Description of methods to be used
7) Statement of how the data are to be analyzed
8) Signatures of student, SIGN faculty advisor, and project preceptor
Student will return when notified of winning:
1) A Statement of Intent form, signed by student and preceptor, supplied with winner notification letter.
2) W-9 or W-8BEN Tax form for Canadian citizens
Student will submit after project completion and before September 6, 2014:
1) A one-page abstract of the project
2) Evaluation forms completed by the student and preceptor, supplied with the winner notification letter.
3) Students are encouraged to submit completed abstracts to the AAN or ANA and/or display their project at the SIGN meeting and/or CD/PD Conference during the Educational Tools Session at the AAN Annual Meeting.